Breast cancer registry for advanced disease in southeast Netherlands
Part of Cancer, Skin clinical trials.
This trial is a cancer registry, meaning your medical information is collected and stored for people with advanced breast cancer. It can help researchers learn from real-world care patterns and outcomes across multiple hospitals in southeast Netherlands.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have advanced breast cancer that is new (de novo) or has come back (recurrent) since 2007
- Your cancer is diagnosed as advanced, or you have been diagnosed and/or treated for advanced breast cancer
- Your care was received at one of the participating hospitals in the Netherlands during the study’s inclusion years
- The study mainly covers hospitals in southeast Netherlands, including Maastricht UMC+ and others listed in the criteria
- There are no specific exclusion criteria listed for this registry trial
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how well and how safely different combinations of cancer drugs work for people with metastatic or inoperable locally advanced breast cancer. It may help by finding a better treatment option and collecting information to guide future care.
This study looks at people with advanced breast cancer to better understand recurrence by using information from recent scans. It may help researchers improve how advanced disease is assessed and followed over time.
This study builds a database of people with localized or locally advanced prostate cancer to better understand patient-reported outcomes (your experiences and quality-of-life). It may help improve future care by collecting consistent feedback from patients.
This study follows people with breast cancer who receive radiation at UMC Utrecht. It uses routinely collected medical data and questionnaires to better understand outcomes over the long term.
This trial studies the best ways to give chemotherapy before and after surgery for stage III triple-negative breast cancer. It aims to improve treatment outcomes by using a personalized approach and patient-reported data.
This study uses information from a European registry to learn how real-world treatments work for advanced non-melanoma skin cancers. It may help doctors improve care in the future, especially for people who have had surgery and radiation or who cannot have curative treatments.
Hear when a new Advanced Breast Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.